Growth cycle-dependent generation of complement-resistant Leishmania promastigotes
- PMID: 3973390
Growth cycle-dependent generation of complement-resistant Leishmania promastigotes
Abstract
The ability of in vitro grown Leishmania promastigotes to resist lysis by complement and survive in undiluted human serum was related to the species of Leishmania and the growth phase in culture. Promastigotes from log phase cultures were always killed in undiluted serum, whereas survival of stationary phase promastigotes varied among species. All L. major and L. m. amazonensis were killed, while up to 30% of L.b. panamensis and 10% of L. donovani survived. Lysis of promastigotes by human serum was inhibited in heat-inactivated serum and EDTA-chelated serum, indicating that activation of complement was responsible for killing. Therefore, during growth in vitro, some strains of Leishmania promastigotes can undergo development from a complement-susceptible to -resistant stage. Stationary phase promastigotes of L.b. panamensis which survived in undiluted human serum were capable of subsequent growth in culture, and were also able to initiate infection in Mystromys albicaudatus. Organisms selected on the basis of complement resistance were more infective for M. albicaudatus than either log phase promastigotes or unselected promastigotes from stationary cultures. These data support the notion that the life cycle of Leishmania includes an infective stage promastigote which is generated during growth within the sandfly and which, on inoculation, is able to survive the potentially lethal effect of normal serum before uptake by host macrophages.
Similar articles
-
Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.J Immunol. 1984 Mar;132(3):1501-5. J Immunol. 1984. PMID: 6363545
-
Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.J Immunol. 1985 Jul;135(1):564-9. J Immunol. 1985. PMID: 2582050
-
Killing of Leishmania tropica amastigotes by factors in normal human serum.J Immunol. 1984 Feb;132(2):893-7. J Immunol. 1984. PMID: 6690622
-
Leishmania, macrophages and complement: a tale of subversion and exploitation.Parasitology. 1997;115 Suppl:S9-23. doi: 10.1017/s0031182097001789. Parasitology. 1997. PMID: 9571687 Review.
-
Early mechanisms of Leishmania infection in human blood.Microbes Infect. 2003 May;5(6):507-13. doi: 10.1016/s1286-4579(03)00071-6. Microbes Infect. 2003. PMID: 12758280 Review.
Cited by
-
In vitro and in vivo characterization of an ail mutant of Yersinia enterocolitica.Infect Immun. 1995 Jul;63(7):2541-8. doi: 10.1128/iai.63.7.2541-2548.1995. Infect Immun. 1995. PMID: 7790067 Free PMC article.
-
Cytolytic activity in the genus Leishmania: involvement of a putative pore-forming protein.Infect Immun. 1996 Oct;64(10):3975-82. doi: 10.1128/iai.64.10.3975-3982.1996. Infect Immun. 1996. PMID: 8926057 Free PMC article.
-
Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy.J Exp Med. 1986 Oct 1;164(4):1332-7. doi: 10.1084/jem.164.4.1332. J Exp Med. 1986. PMID: 3531384 Free PMC article.
-
Reverse Epidemiology: An Experimental Framework to Drive Leishmania Biomarker Discovery in situ by Functional Genetic Screening Using Relevant Animal Models.Front Cell Infect Microbiol. 2018 Sep 19;8:325. doi: 10.3389/fcimb.2018.00325. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 30283743 Free PMC article. Review.
-
Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages.Immunology. 1987 Apr;60(4):559-63. Immunology. 1987. PMID: 2953670 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical